Suppr超能文献

静脉注射胰高血糖素试验在胰岛素瘤中的诊断价值

Diagnostic value of intravenous glucagon test in insulinoma.

作者信息

Oneda A, Maruhama Y, Itabashi H, Horigome K, Yanbe A

出版信息

Tohoku J Exp Med. 1975 Jul;116(3):205-11. doi: 10.1620/tjem.116.205.

Abstract

The intravenous glucagon test was performed in 11 patients with insulinoma and the diagnostic significance of the test was studied in comparison with the glucose test, the tolbutamide test and the arginine test. The curves of plasma insulin following the intravenous administration of glucagon were markedly different and strange in those patients with insulinoma compared with the normal controls. The maximal levels of plasma insulin ranged from 85 to 400 muU/ml, exceeding the normal range in 10 out of 11 patients, or 91%. Increased levels in the maximal plasma insulin were observed in 63%, 100% and 56% through the glucose test, the tolbutamide test and the arginine test, respectively. The distribution of the insulin areas, calculated from the insulin curves during these tests, was shown to be similar to that of the maximal levels of plasma insulin. There was no significant correlations between the maximal levels of plasma insulin in the glucagon test and the glucose test, the tolbutamide test or the arginine test. The present experiment demonstrated that the intravenous glucagon test, next to the tolbutamide test, caused a large increase in plasma insulin, and therefore, that this test is one of the most useful tools among the provocation tests, for the diagnosis of insulinoma.

摘要

对11例胰岛素瘤患者进行了静脉注射胰高血糖素试验,并与葡萄糖试验、甲苯磺丁脲试验和精氨酸试验相比较,研究了该试验的诊断意义。与正常对照组相比,胰岛素瘤患者静脉注射胰高血糖素后血浆胰岛素曲线明显不同且怪异。血浆胰岛素的最高水平在85至400 μU/ml之间,11例患者中有10例(即91%)超过正常范围。通过葡萄糖试验、甲苯磺丁脲试验和精氨酸试验分别观察到,最高血浆胰岛素水平升高的患者比例分别为63%、100%和56%。根据这些试验期间的胰岛素曲线计算出的胰岛素面积分布与血浆胰岛素最高水平的分布相似。胰高血糖素试验中血浆胰岛素的最高水平与葡萄糖试验、甲苯磺丁脲试验或精氨酸试验之间无显著相关性。本实验表明,静脉注射胰高血糖素试验仅次于甲苯磺丁脲试验,可使血浆胰岛素大幅升高,因此,该试验是激发试验中诊断胰岛素瘤最有用的工具之一。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验